The Traceability Gap: Managing Risk Across Suppliers Beyond Tier 1
click here to discover importer exporter profiles & logistic partners
Shipments
Trading Partners
Markets
Products/HS Code
Imports and Exports Data of
novartis pharma ag
lichtstrasse 35 basel bs 4056 switzerland, switzerland
novartis pharma ag is based out of switzerland with 636 import shipments and 9,991 export shipments recorded in global import export data.
Trade Trends of novartis pharma ag
from Jan 2022 to Sept 2025Shipments Imported: 636
As Buyer Trade Value (USD): $3.2 M
Shipments Exported: 9.99 K
As Supplier Trade Value (USD): $3.08 B
Import and Export shipments of "novartis pharma ag"
| Consignee Name | HS Code | Shipment Date |
|---|---|---|
| 300420 | Jan 20, 2026 | |
novartis pharma ag | 300420 | Jan 20, 2026 |
novartis pharma ag | 300420 | Jan 20, 2026 |
novartis pharma ag | 300420 | Jan 20, 2026 |
novartis pharma ag | 300420 | Jan 20, 2026 |
Trademo turns 3B+ shipment records and 15M+ company profiles into actionable data for trade prospecting. Subscribe to Trademo Intel to grow the pipeline.
Solutions Built for Every Stage of Global Trade
Global Trade Management
Discover end-to-end compliance automation across classification, screening, and duties.
Know more
Intel
Discover high-potential prospects, qualify opportunities, and grow your pipeline.
Know more
Source Atlas
Discover suppliers, compare sourcing markets, and make smarter sourcing decisions.
Know more
Trading Partners of novartis pharma ag
Top Companies "novartis pharma ag" is importing from (by Value USD)
| Supplier | 2025 | 2023 | 2022 |
|---|---|---|---|
novartis saglik gida ve tarim urunleri sanayi ve ticaret as | - | 2.29 M | - |
novartis ecuador sa | 909.41 K | - | - |
| - | - | 0 |
Top Companies "novartis pharma ag" is exporting to (by Value USD)
| Buyer | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
novartis pharma llc | - | - | 132.29 M | 694.66 M | 392.58 M |
novartis de colombia sa | 8.57 M | 172.01 M | 145.05 M | 190.17 M | 11.86 M |
| - | 112.33 M | 104.88 M | 88.53 M | 49.92 M |
| - | - | 19.08 M | 169.89 M | 124.05 M |
| 4.87 M | 82.65 M | 43.22 M | 45.66 M | 48.4 M |
Markets in which novartis pharma ag trades
Top Countries "novartis pharma ag" is exporting to (by Value USD)
| Importing Country | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
 russia | - | - | 151.38 M | 864.55 M | 516.62 M |
 colombia | 8.57 M | 172.01 M | 145.05 M | 190.17 M | 11.86 M |
 vietnam | - | 112.33 M | 104.88 M | 88.53 M | 49.92 M |
 philippines | 4.87 M | 82.65 M | 43.28 M | 46.38 M | 49.26 M |
 pakistan | - | 31.6 M | 54.4 M | 66.36 M | 55.49 M |
Top Port Pairs of "novartis pharma ag" as Buyer (by Value USD)
| Port Pairs | 2022 |
|---|---|
basel -> ho chi minh city | - |
Products/HS Codes traded by novartis pharma ag
Top HS Codes Imported by "novartis pharma ag"
USD 2.98 M | 37.42%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
USD 217.28 K | 6.92%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
USD 0 | 1.26%
Miscellaneous edible preparations Food preparations not elsewhere specified or included. - Other
Miscellaneous edible preparations Food preparations not elsewhere specified or included. - Other
USD 0 | 0.16%
Products of animal origin, not elsewhere specified or included Animal products not elsewhere specified or included; dead animals of Chapter 1 or 3, unfit for human consumption. -- Other
Products of animal origin, not elsewhere specified or included Animal products not elsewhere specified or included; dead animals of Chapter 1 or 3, unfit for human consumption. -- Other
USD 0 | 0.16%
Inorganic chemicals; organic or inorganic compounds of precious metals, of rare-earth metals, of radioactive elements or of isotopes Isotopes other than those of heading 28.44; compounds, inorganic or organic, of such isotopes, whether or not chemically defined. - Other
Inorganic chemicals; organic or inorganic compounds of precious metals, of rare-earth metals, of radioactive elements or of isotopes Isotopes other than those of heading 28.44; compounds, inorganic or organic, of such isotopes, whether or not chemically defined. - Other
Top HS Codes Exported by "novartis pharma ag"
USD 1.88 B | 74.82%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
USD 393.27 M | 6.10%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
USD 87.19 M | 4.95%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other, containing antibiotics
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other, containing antibiotics
USD 34.63 M | 2.47%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. -- Other
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. -- Other
USD 176.75 M | 2.13%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Other
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Other
Intel
Identify in-market buyers, prioritize high-potential accounts, and accelerate pipeline growth.
Similar Companies to novartis pharma ag
Companies importing similar HS Codes as of "novartis pharma ag" in switzerland
Companies exporting similar products as of "novartis pharma ag" in switzerland
Companies exporting similar HS Codes as of "novartis pharma ag" in switzerland
Other Buyers and Suppliers in switzerland who deal in similar products like novartis pharma ag
Other suppliers who export similar products like "novartis pharma ag"
Explore Transformation Stories
How a US Freight Forwarder Generated
4x More Leads at $1 Cost Per Lead
Trademo’s global trade intelligence platform has allowed us to find leads easily, boosting the team’s productivity and making the process simpler.
Iliana Rodriguez
Operations Team Leader
Frequently Asked Questions
What products does Novartis Pharma Ag export?
Novartis Pharma Ag is known to export dry ice, temperature sensor, collection tube, and related goods, as per verified global trade insights.
Who are the top buyers purchasing from Novartis Pharma Ag?
According to trade records, some of the top buyers of Novartis Pharma Ag include Novartis Pharma Llc, Novartis De Colombia Sa And Novartis Vietnam Co Ltd.
Who are the top manufacturers of Novartis Pharma Ag?
Some of the top manufacturers working with Novartis Pharma Ag include Novartis Saglik Gida Ve Tarim Urunleri Sanayi Ve Ticaret As, Novartis Ecuador Sa And Novartis Vietnam Co Ltd.
Which countries does Novartis Pharma Ag trade with?
Customs data shows that Novartis Pharma Ag is most active in trade with countries such as Russia, Colombia And Vietnam.
How many shipments has Novartis Pharma Ag in last 12 months?
In last 12 months, Novartis Pharma Ag has been linked to 10.63 K verified shipments tracked through international trade data.
What is the total value of imports made by Novartis Pharma Ag in last 12 months?
The total recorded import value of Novartis Pharma Ag is estimated at $3.2 M till date, based on aggregated global shipment sources.
What is the total export value of Novartis Pharma Ag in last 12 months?
The total recorded export value of Novartis Pharma Ag is estimated at $3.08 B till date, based on aggregated global shipment sources.
How can I analyze Novartis Pharma Ag global trade network?
With Trademo, you can explore Novartis Pharma Ag complete trade ecosystem including buyers, manufacturers, shipment volumes, and trade routes, helping you identify opportunities and risks.
APIs
Data License
Plans
Directories
Company
Location
United States
3000 El Camino Real, Building 4, Suite 200, Palo Alto, California 94306
India
2nd Floor, Plot No. 136, Sector 44, Gurugram, Haryana 122003
All rights reserved | Terms of use Copyright ©2025 Trademo Technologies Inc.